This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Consiglio Nazionale Delle Ricerche. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Valeria Sanginario: Innovator in Injectable Composite Materials
Introduction
Valeria Sanginario is a prominent inventor based in Pozzuoli, Italy. She has made significant contributions to the field of biomedical engineering, particularly in the development of materials suitable for bone substitution. Her innovative work has the potential to enhance medical treatments and improve patient outcomes.
Latest Patents
Valeria holds a patent for an injectable composite material that is suitable for use as a bone substitute. This invention involves a new composite material that comprises a reactive ceramic phase based on tricalcium phosphate and an organic phase consisting of a polyvinyl alcohol hydrogel. By varying the concentration of these two phases, it is possible to modulate the mechanical and injectability properties of the material. This advancement represents a significant step forward in the field of regenerative medicine.
Career Highlights
Valeria is affiliated with the National Research Council (Consiglio Nazionale Delle Ricerche), where she continues to engage in groundbreaking research. Her work focuses on developing innovative materials that can be utilized in various medical applications. With her expertise, she has positioned herself as a leader in her field.
Collaborations
Throughout her career, Valeria has collaborated with esteemed colleagues, including Luigi Ambrosio and Maria Pau Ginebra. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the advancement of research in biomedical engineering.
Conclusion
Valeria Sanginario is a trailblazer in the development of injectable composite materials for bone substitution. Her innovative patent and collaborative efforts highlight her commitment to advancing medical technology. Her contributions are poised to make a lasting impact in the field of regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
